FERRONE, MARCO
FERRONE, MARCO
Dipartimento di Ingegneria Chimica, dell'Ambiente e delle Materie prime (attivo dal 01/01/1900 al 31/10/2009)
Settore ING-IND/24 - Principi di Ingegneria Chimica
"Fatty" nucleoside analogs as HCV NS5b inhibitors
2004-01-01 Pricl, Sabrina; Fermeglia, Maurizio; Ferrone, Marco; Coslanich, Alessandro; Paneni, Maria Silvia; Manfredini, S.; Angusti, A.; La Colla, P.; Mura, M.
A cyclodextrin-bioconjugate as carrier for anticancer drugs: from synthesis to molecular modeling
2002-01-01 Pricl, Sabrina; Fermeglia, Maurizio; Ferrone, Marco; Lodi, A.; Caliceti, P.; Salmaso, S.; Fornasier, R.
A new mutation affecting the ATP pocket of kit receptor in patients with GIST showing acquired resistance to Imatinib: A coupled experimental and modeling investigation
2004-01-01 Pricl, Sabrina; Coslanich, A.; Fermeglia, Maurizio; Ferrone, Marco; Paneni, Maria Silvia; Tamborini, E.; Pilotti, S.; Pierotti, M. A.
A new twist for an old song. The DABO story revisited
2006-01-01 Pricl, Sabrina; Ferrone, Marco; Posocco, Paola; Pavan, G. M.; Fermeglia, Maurizio; La Colla, P.; Loddo, R.
A simple but effective three-dimensional chemical feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA-polymerase inhibitors
2005-01-01 DI SANTO, R.; Fermeglia, Maurizio; Ferrone, Marco; Paneni, Maria Silvia; Costi, R.; Artico, M.; Roux, A.; Gabriele, M.; Tardiff, K. D.; Siddiqui, A.; Pricl, Sabrina
A talk on the motor side. The free energy for mutating V186 and F244 to Leucine in beta-myosin and its ATP binding
2004-01-01 Paneni, Maria Silvia; Ferrone, Marco; Coslanich, A:; Fermeglia, Maurizio; Pricl, Sabrina; Miertus, S.; Frecer, V.; Carniel, E.; Mestroni, L.
A Tumor (GIST), a Mutated Gene (c-kit), and a Molecular Inhibitor (Imatinib): Insights from Computer Simulations
2003-01-01 Pricl, Sabrina; Coslanich, A.; Fermeglia, Maurizio; Ferrone, Marco; Albertini, V.; Bonadiman, L.; Tamborini, E.; Pierotti, M. A.; Pilotti, S.
Alternative Refrigerants: Thermophysical Properties and Phase equilibra by computational chemistry
2002-01-01 Fermeglia, Maurizio; Ferrone, Marco; Pricl, Sabrina
Analogies in imatinib-resistant threonine-to-isoleucine mutation in bcr-abl, kit and pdgfra: a combined experimental/computational approach
2004-01-01 Pricl, Sabrina; Coslanich, Alessandro; Fermeglia, Maurizio; Ferro, M.; Ferrone, Marco; Paneni, Maria Silvia; Tamborini, E.; Negri, T.; Lagonigro, S.; Greco, A.; Gabanti, E.; Pierotti, M. A.; Pilotti, S.
Angels and demons of the guardian of the genome. A coupled modeling-biochemical study of p53 mutants in ovarian cancer.
2006-01-01 Pricl, Sabrina; Ferrone, Marco; Paneni, Maria Silvia; Cosoli, P.; Fermeglia, Maurizio; Perrone, F.; Da Riva, L.; Tamborini, E.; Suardi, S.; Pierotti, M. P.; Pilotti, S.
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach
2006-01-01 Banfi, Elena; Scialino, G.; Zampieri, Daniele; Mamolo, MARIA GRAZIA; Vio, Luciano; Ferrone, Marco; Fermeglia, Maurizio; Paneni, M. S.; Pricl, Sabrina
Antifungal and antimycobacterial activity of new N1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: a combined experimental and computational approach
2004-01-01 Mamolo, MARIA GRAZIA; Zampieri, Daniele; Falagiani, V; Vio, Luciano; Fermeglia, Maurizio; Ferrone, Marco; Pricl, Sabrina; Banfi, Elena; Scialino, G.
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations
2005-01-01 Mamolo, MARIA GRAZIA; Zampieri, Daniele; Vio, Luciano; Fermeglia, Maurizio; Ferrone, Marco; Pricl, Sabrina; Scialino, G; Banfi, Elena
Binding at the core. Computational study of structural and ligand binding properties of naphthiridine based dendrimers
2007-01-01 Posocco, Paola; Ferrone, Marco; Fermeglia, Maurizio; Pricl, Sabrina
C-kit mutants in GISTs and their interaction with STI 571: Insights from computer simulations and clinical trials.
2003-01-01 Pricl, Sabrina; Ferrone, Marco; Fermeglia, Maurizio; E., Tamborini; D., Delia; M. A., Pierotti; S., Pilotti
Can computational structural biology be of help in rationalizing clinical data? The Abl/imatinib paradigm
2005-01-01 Pricl, Sabrina; Tamborini, E.; Ferrone, Marco; Paneni, Maria Silvia; Fermeglia, Maurizio; Pierotti, M. A.; Pilotti, S.
Can inhibitors of HIV integrase work on HCV polymerase?
2002-01-01 Artico, M.; Costi, R.; Di Santo, R.; Fermeglia, Maurizio; Ferrone, Marco; Manfredini, S.; Pricl, Sabrina
Changes and challenges: GIST, mutated C-KIT and imatinib resistance
2005-01-01 Pricl, Sabrina; Ferrone, Marco; Paneni, Maria Silvia; Cosoli, P.; Fermeglia, Maurizio; Pierotti, M. A.; Pilotti, S.; Tamborini, E.
Chasing the evaders. Design, synthesis, activity and molecular modelling of a new small molecule with activity against drug-resistant HIV-1-mutants
2006-01-01 Pricl, Sabrina; Ferrone, Marco; Posocco, Paola; Fermeglia, Maurizio; Sanna, G.; Collu, G.; La Colla, P.; Loddo, R.; Sias, A.; Piras, S.; Carta, A.
Chemical Engineering at the edge of life science. Selected cases of molecular simulations and free-energy calculations for biological and medical applications.
2002-01-01 Ferrone, Marco; Fermeglia, Maurizio; Pricl, Sabrina